{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20200925",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "64673",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761122s005lbl.pdf",
              "date": "20200925",
              "type": "Label"
            },
            {
              "id": "64739",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/761122Orig1s005ltr.pdf",
              "date": "20200929",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20190912",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "59994",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/125526Orig1s012,%20761122Orig1s002,s003ltr.pdf",
              "date": "20190913",
              "type": "Letter"
            },
            {
              "id": "60002",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125526s012,761122s002s003lbl.pdf",
              "date": "20190913",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20220122",
          "review_priority": "N/A",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "69958",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/125526Orig1s019; 761122Orig1s008ltr.pdf",
              "date": "20220125",
              "type": "Letter"
            },
            {
              "id": "69973",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761122s008,125526s019lbl.pdf",
              "date": "20220126",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "11",
          "submission_status": "AP",
          "submission_status_date": "20230308",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "73775",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125526Orig1s021,761122Orig1s011Corrected_lbl.pdf",
              "date": "20230316",
              "type": "Label"
            },
            {
              "id": "73785",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/125526Orig1s021;761122Orig1s011Corrected_ltr.pdf",
              "date": "20230317",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20210729",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "68249",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/761122Orig1s006; 125526Orig1s018ltr.pdf",
              "date": "20210802",
              "type": "Letter"
            },
            {
              "id": "68266",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761122s006,125526s018lbl.pdf",
              "date": "20210802",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20190606",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 3",
          "submission_class_code_description": "Type 3 - New Dosage Form",
          "application_docs": [
            {
              "id": "58987",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761122s000lbl.pdf",
              "date": "20190607",
              "type": "Label"
            },
            {
              "id": "58995",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/761122Orig1s000ltr.pdf",
              "date": "20190607",
              "type": "Letter"
            },
            {
              "id": "59839",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/761122Orig1s000TOC.html",
              "date": "20190826",
              "type": "Review"
            },
            {
              "id": "66960",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/447_761122_mepolizumab unireview prea.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20190912",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "59993",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/125526Orig1s012,%20761122Orig1s002,s003ltr.pdf",
              "date": "20190913",
              "type": "Letter"
            },
            {
              "id": "60001",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125526s012,761122s002s003lbl.pdf",
              "date": "20190913",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "22",
          "submission_status": "AP",
          "submission_status_date": "20250806",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "83062",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761122Orig1s022ltr.pdf",
              "date": "20250807",
              "type": "Letter"
            },
            {
              "id": "83128",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761122s022lbl.pdf",
              "date": "20250819",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "BLA761122",
      "sponsor_name": "GLAXOSMITHKLINE",
      "openfda": {
        "application_number": [
          "BLA761122"
        ],
        "brand_name": [
          "NUCALA"
        ],
        "generic_name": [
          "MEPOLIZUMAB"
        ],
        "manufacturer_name": [
          "GlaxoSmithKline LLC"
        ],
        "product_ndc": [
          "0173-0892",
          "0173-0881",
          "0173-0904"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "MEPOLIZUMAB"
        ],
        "rxcui": [
          "1720601",
          "1720606",
          "2170990",
          "2170993",
          "2173820",
          "2173822",
          "2596444",
          "2596445"
        ],
        "spl_id": [
          "869b75ba-b2a0-406e-9ed2-136b75763d78"
        ],
        "spl_set_id": [
          "fefb887c-e4ac-431e-8893-e9d1a5a63fea"
        ],
        "package_ndc": [
          "0173-0881-01",
          "0173-0881-61",
          "0173-0892-01",
          "0173-0892-42",
          "0173-0892-61",
          "0173-0892-63",
          "0173-0904-42"
        ],
        "nui": [
          "N0000191872",
          "N0000191871"
        ],
        "pharm_class_epc": [
          "Interleukin-5 Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Interleukin-5 Antagonists [MoA]"
        ],
        "unii": [
          "90Z2UF0E52"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "NUCALA",
          "active_ingredients": [
            {
              "name": "MEPOLIZUMAB",
              "strength": "100MG/ML"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}